Indianapolis, IN, United States of America

Thomas Albert Engler

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Thomas Albert Engler: Innovator in Cancer Treatment

Introduction

Thomas Albert Engler is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 10 patents to his name, Engler's work has the potential to impact the lives of many patients.

Latest Patents

Engler's latest patents include innovative compounds such as Pyrido[2,3-d]pyrimidin-4-one compounds, which serve as tankyrase inhibitors. These compounds, along with formulations containing them, are designed for use as inhibitors of tankyrase 1 and 2. Another notable patent focuses on the potentiation of cancer chemotherapy through a specific compound that improves treatment methods for gastric cancer, ovarian cancer, non-small cell lung cancer, and colorectal cancer. This patent also details pharmaceutical compositions and processes for preparing these compositions.

Career Highlights

Engler is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in drug development. His work at Eli Lilly has allowed him to explore and develop groundbreaking treatments that address critical health challenges.

Collaborations

Engler has collaborated with talented coworkers such as Sushant Malhotra and Kelly Wayne Furness. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Thomas Albert Engler's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…